Drew Wilfahrt

3PUBLICATIONS
42CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Molecular targetsApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (3)

|Aug 19, 2025
Reprogramming CD8+ T-cell Branched N-Glycosylation Limits Exhaustion, Enhancing Cytotoxicity and Tumor Killing.

Catarina M Azevedo, Bingxian Xie, William G Gunn

|Jul 31, 2025
Sucralose Consumption Ablates Cancer Immunotherapy Response through Microbiome Disruption.

Kristin M Morder, Madison Nguyen, Drew N Wilfahrt

|Aug 08, 2023
An oncolytic virus-delivered TGFβ inhibitor overcomes the immunosuppressive tumor microenvironment.

Kristin DePeaux, Dayana B Rivadeneira, Konstantinos Lontos

Pageof 1